Toll Free: 1-888-928-9744

Bone Cement - Medical Devices Pipeline Assessment, 2016

Published: May 9, 2016 | Pages: 51 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Bone Cement - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Bone Cement - Medical Devices Pipeline Assessment, 2016" provides an overview of Bone Cement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Cement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bone Cement under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bone Cement and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Bone Cement under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 Bone Cement Overview 6 3 Products under Development 7 3.1 Bone Cement - Pipeline Products by Stage of Development 7 3.2 Bone Cement - Pipeline Products by Segment 8 3.3 Bone Cement - Pipeline Products by Territory 9 3.4 Bone Cement - Pipeline Products by Regulatory Path 10 3.5 Bone Cement - Pipeline Products by Estimated Approval Date 11 4 Bone Cement - Pipeline Products under Development by Companies 12 4.1 Bone Cement Companies - Pipeline Products by Stage of Development 12 4.2 Bone Cement - Pipeline Products by Stage of Development 13 5 Bone Cement Companies and Product Overview 14 5.1 aap Implantate AG Company Overview 14 5.1.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 14 5.2 Biofix Medical Technologies Company Overview 17 5.2.1 Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 17 5.3 Bone-Rad Therapeutics, Inc. Company Overview 18 5.3.1 Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18 5.4 Exactech, Inc. Company Overview 19 5.4.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19 5.5 Graftys SAS Company Overview 21 5.5.1 Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview 21 5.6 Meta Biomed Co., Ltd. Company Overview 22 5.6.1 Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22 5.7 Onbone Oy Company Overview 24 5.7.1 Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview 24 5.8 Orthox Ltd. Company Overview 25 5.8.1 Orthox Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25 5.9 Osseon Therapeutics, Inc. Company Overview 26 5.9.1 Osseon Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26 5.10 Ozics AG Company Overview 27 5.10.1 Ozics AG Pipeline Products & Ongoing Clinical Trials Overview 27 5.11 Queen's University Belfast Company Overview 29 5.11.1 Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview 29 5.12 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 30 5.12.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 30 5.13 Synthes, Inc. Company Overview 31 5.13.1 Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.14 Teknimed S.A. Company Overview 32 5.14.1 Teknimed S.A. Pipeline Products & Ongoing Clinical Trials Overview 32 5.15 University of Limerick Company Overview 35 5.15.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 35 5.16 Zimmer Biomet Holdings, Inc. Company Overview 38 5.16.1 Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38 6 Bone Cement- Recent Developments 40 6.1 Apr 20, 2016: Stryker reports first quarter 2016 results 40 6.2 Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019 41 6.3 Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046 41 6.4 Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026 41 6.5 Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021 42 6.6 Jan 28, 2016: Vexim Raises USD11.3 Million in Private Placement of Shares 42 6.7 Jan 26, 2016: Stryker Reports 2015 Results and 2016 Outlook 42 6.8 Jan 26, 2016: Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer 43 6.9 Jan 12, 2016: Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance 44 6.10 Oct 22, 2015: Stryker Reports Third Quarter 2015 Results 45 6.11 Oct 19, 2015: U.S. Supreme Court To Hear Stryker's Appeal In Zimmer Patent Infringement Suit 46 6.12 Oct 14, 2015: Ziehm Imaging and Stryker Partner to Provide Surgical Navigation with Ziehm Vision RFD 3D 46 6.13 Jul 23, 2015: Stryker Reports Second Quarter 2015 Results 47 7 Appendix 48 7.1 Methodology 48 7.2 About GlobalData 50 7.3 Contact Us 51 7.4 Disclaimer 51
List of Tables
Table 1: Bone Cement - Pipeline Products by Stage of Development 7 Table 2: Bone Cement - Pipeline Products by Segment 8 Table 3: Bone Cement - Pipeline Products by Territory 9 Table 4: Bone Cement - Pipeline Products by Regulatory Path 10 Table 5: Bone Cement - Pipeline Products by Estimated Approval Date 11 Table 6: Bone Cement Companies - Pipeline Products by Stage of Development 12 Table 7: Bone Cement - Pipeline Products by Stage of Development 13 Table 8: aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 14 Table 9: Ag Cement - Product Status 15 Table 10: Ag Cement - Product Description 15 Table 11: C-Plug G - Product Status 16 Table 12: C-Plug G - Product Description 16 Table 13: Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 17 Table 14: Injectable Glass Ionomer Cement - Product Status 17 Table 15: Injectable Glass Ionomer Cement - Product Description 17 Table 16: Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18 Table 17: Spine-Rad Brachytherapy Bone Cement - Product Status 18 Table 18: Spine-Rad Brachytherapy Bone Cement - Product Description 18 Table 19: Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19 Table 20: Bone Cement - Product Status 20 Table 21: Bone Cement - Product Description 20 Table 22: Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview 21 Table 23: Phosphocalcic Cement - Product Status 21 Table 24: Phosphocalcic Cement - Product Description 21 Table 25: Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22 Table 26: Bone Cement - Product Status 23 Table 27: Bone Cement - Product Description 23 Table 28: Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview 24 Table 29: BIOCEMENT - Product Status 24 Table 30: BIOCEMENT - Product Description 24 Table 31: Orthox Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25 Table 32: Fiber-Reinforced Cement - Product Status 25 Table 33: Fiber-Reinforced Cement - Product Description 25 Table 34: Osseon Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26 Table 35: Monetite - Based Injectable Orthopaedic Cement - Product Status 26 Table 36: Monetite - Based Injectable Orthopaedic Cement - Product Description 26 Table 37: Ozics AG Pipeline Products & Ongoing Clinical Trials Overview 27 Table 38: CompO6 Bone Reinforcement Composite - Product Status 27 Table 39: CompO6 Bone Reinforcement Composite - Product Description 27 Table 40: CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Status 28 Table 41: CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Description 28 Table 42: Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview 29 Table 43: Spinal Cement - Product Status 29 Table 44: Spinal Cement - Product Description 29 Table 45: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 30 Table 46: Bone Cement - Product Status 30 Table 47: Bone Cement - Product Description 30 Table 48: Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 49: Statin Eluting Bone Cements - Product Status 31 Table 50: Statin Eluting Bone Cements - Product Description 31 Table 51: Teknimed S.A. Pipeline Products & Ongoing Clinical Trials Overview 32 Table 52: Cemfix 1 - Product Status 33 Table 53: Cemfix 1 - Product Description 33 Table 54: Cemfix 3 - Product Status 34 Table 55: Cemfix 3 - Product Description 34 Table 56: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 35 Table 57: Bioactive Adhesive Cement - Product Status 35 Table 58: Bioactive Adhesive Cement - Product Description 35 Table 59: Dual Calcium Phosphate Paste System - Product Status 36 Table 60: Dual Calcium Phosphate Paste System - Product Description 36 Table 61: Heracap - Product Status 37 Table 62: Heracap - Product Description 37 Table 63: Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38 Table 64: Cobalt Stage One Acrylic Spacer Cement - Product Status 39 Table 65: Cobalt Stage One Acrylic Spacer Cement - Product Description 39 Table 66: Glossary 49


List of Figures
Figure 1: Bone Cement - Pipeline Products by Stage of Development 7 Figure 2: Bone Cement - Pipeline Products by Segment 8 Figure 3: Bone Cement - Pipeline Products by Territory 9 Figure 4: Bone Cement - Pipeline Products by Regulatory Path 10 Figure 5: Bone Cement - Pipeline Products by Estimated Approval Date 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify